Clinical Trials · NCT01338987

Pilot Study of Leuprolide to Improve Immune Function After Allogeneic Bone Marrow Transplantation

Name: Pilot Study of Leuprolide to Improve Immune Function After Allogeneic Bone Marrow Transplantation
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 2Gonadorelin

Phase: Phase 2
Recruitment status: Completed
Sponsor: National Cancer Institute (NCI)
Enrollment: 76
Start date: Apr 2011
Locations: 3 sites, United States
Primary endpoint: Percentage of B Cells at One Year Post-transplant in Participants Who Did/Did Not Receive Leuprolide Following Bone Marrow Transplant (BMT)

View Gonadorelin compound reference